At a glance

ClinicalIndex Comparison Record

N/ACompleted· 174 enrolled

Drug / intervention

PET/CT results with TOF/without TOFother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03914950

NCT03914950N/ACompleted

Compare CT.gov

Evaluation of the Diagnostic Value of TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer

Medical University of Graz·interventional·Posted Apr 16, 2019·Updated May 29, 2020

In Brief

A clinical study evaluating PET/CT results with TOF/without TOF for Pancreatic Cancer and 2 related conditions. Completed, enrolled 174 participants.

Detailed Summary

Aim of the prospective study is a better differentiation of benign and malignant lesions in the pancreas in patients with suspected pancreatic cancer using images 30 and 90 min p.i. (post injectionen) and a diagnostic CT (computed tomography) scan of the abdomen within the Time of Flight (TOF)-18F-FDG-PET/CT and thus an improvement of the quality of PET/CT findings.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsPancreatic Cancer, Pancreatitis, IPMN

Countries--

Collaborators--

Timeline

N/ACompletedFinished

2014201520162017201820192020202120222023202420252026

Enrollment StartFeb 2014

Primary CompletionJan 2019

Study CompletionMar 2019

First PostedApr 2019

TodayJul 2026

First PostedApr 16, 2019

Enrollment StartFeb 7, 2014

Primary CompletionJan 17, 2019

Study CompletionMar 5, 2019

TodayJul 2, 2026

Enrollment to primary: 4.9 yearsPosted 7.2 years ago

Interventions

PET/CT results with TOF/without TOFother

Diagnostic CT of the abdomen or upper abdomen with parenteral contrast medium (Visipaque=Iodixanol) if creatinine, GFR, and TSH levels are within the normal range and oral (water) contrast medium within TOF-18F-FDG PET/CT. In the case of elevated creatine or decreased GFR or TSH levels a diagnostic CT of the abdomen or upper abdomen without contrast medium is performed. Biopsy or FNA or operation of the pancreas.